Kalshi and Polymarket now let you bet on drug approvals, and not everyone is thrilled about it
The emergence of drug approval betting markets raises ethical concerns and potential regulatory challenges, impacting biotech and crypto sectors. The post Kalshi and Polymarket now let you bet on drug approvals, and not...
Archive context
Older archive item. Useful for background and entity history, but not a fresh market-moving signal.
The emergence of drug approval betting markets raises ethical concerns and potential regulatory challenges, impacting biotech and crypto sectors.
The post Kalshi and Polymarket now let you bet on drug approvals, and not everyone is thrilled about it appeared first on Crypto Briefing.
Why this matters
Kalshi is showing up inside the Prediction Markets theme, so this story is worth tracking for follow-through rather than treating it as a one-off headline.
Original source
Read on Crypto BriefingRelated market context
Polymarket’s expansion into US stocks raises regulatory concerns
Polymarket's US stock expansion highlights regulatory challenges, potentially reshaping prediction markets and impacting industry...
Polymarket introduces self-exclusion features and deposit caps to address gambling risks
Polymarket's new safety features may influence regulatory standards for prediction markets, potentially reshaping their legal land...
CFTC investigates Adam Kinzinger over Kalshi trades tied to his own pardon
The CFTC is investigating Adam Kinzinger over Kalshi prediction market trades tied to his own presidential pardon, netting him jus...
XRP Price Prediction: Binance XRP Scarcity Index Hits 20-Month Low
XRP is trading at $1.50, down more than 1% over 24 hours, as Binance’s scarcity index signals a sharp reversal in exchange supply...
Kalshi in Advanced Talks for $1B Raise at $40B Valuation: Reuters
Prediction-market exchange Kalshi is in advanced talks to raise about $1 billion at a roughly $40 billion valuation from existing...
Kalshi ends volume incentive program effective October 13
Kalshi's program termination may reduce trading incentives, potentially impacting market liquidity and pricing efficiency in predi...